Day One
Tuesday, May 21
11:00 am
-
12:00 pm
PRECONFERENCE WORKSHOP
All You Ever Needed to Know About Government Funding of Startups
Did you know the U.S. Government is a great source of both financial and expertise support for small businesses? In this session, Chris Sasiela, Director, Innovator SEED Innovator Support Services, from the National Institutes of Health SEED Office will share information about the non-dilutive NIH Small Business award programs, and the resources and programs available to enhance a portfolio startup’s success. Topics will include access to entrepreneurs-in-residence, subject matter experts in regulatory and reimbursement, gap analyses, entrepreneurial training and more.
SPEAKERS
Chris Sasiela
Director Innovator Support Services
National Institutes of Health SEED
Full Bio
1:30 pm
-
1:35 pm
Opening Remarks
SPEAKERS
Arundhati Parmar
Editor-in-Chief
MedCity News
Full Bio
1:35 pm
-
2:15 pm
Investment Trends in Healthcare
Fewer deals, slower investment pace, smaller check sizes, more deal scrutiny and more pragmatic valuations. That is the current reality of investing in healthcare innovation. Paradoxically, does this scenario imply that superior startups are securing funding, increasing the likelihood of them achieving profitability? Gain insights from influential investors as they discuss trends in the healthcare investment arena.
MODERATOR
Jack Stockert
Managing Director
Health2047
Full Bio
SPEAKERS
George Khalife
Vice President of Midwest U.S.
Toronto Stock Exchange & TSX Venture Exchange
Full Bio
Fatima Husain
Co-founder & Managing Partner
Mosaic General Partnership
Full Bio
SPONSORED BY
2:15 pm
-
3:25 pm
Biopharma Pitch Track
Startups focused on oncology
CONTESTANTS
Talus Biosciences
OncoSwab
Modulation Therapeutics
miRecule, Inc.
Enzyme By Design
Amplified Sciences
EMCEE
Frank Vinluan
Senior Biopharma Reporter
Full Bio
JUDGES
Ryan Kole
Partner
VCapital
Full Bio
Meredith Wilkerson
Investment Principal
Plains VC
Full Bio
3:25 pm
-
3:45 pm
Networking Break
3:45 pm
-
4:25 pm
Employers Embrace Value-Based Care
Employers are jumping on value-based care for a number of reasons: VBC aligns with their goals of controlling costs, improving employee health outcomes, enhancing satisfaction, and ensuring the long-term sustainability of their workforce. Hear from prominent employers and their service providers about employer-focused VBC strategies.
MODERATOR
Rivka Friedman
Head of Health Care Innovation, Morgan Health
JPMorgan Chase
Full Bio
SPEAKERS
Cheryl Larson
President and CEO
Midwest Business Group on Health (MBGH)
Full Bio
Steven Knight
Chief Operating Officer
Quantum Health
Full Bio
Henry H. Ting
Senior Vice President, Chief Health & Wellness Officer
Delta
Full Bio
SPONSORED BY
4:25 pm
-
5:35 pm
Healthtech: Payer/Provider Pitch Track
Startups addressing burnout and operational efficiency.
CONTESTANTS
DNASafe
Kemtai
Healcisio
Somnea Health
Syntax Health, Inc.
Samaritan
EMCEE
Marissa Plescia
Reporter
Full Bio
JUDGES
Dipa Mehta
Managing Partner
Cobalt Ventures
Full Bio
Jane Rho
Director, Fund & AI
DaVita Ventures
Full Bio
Jasmi Shah
Managing Director
Cigna Ventures
Full Bio
5:35 pm
-
7:10 pm
Opening Reception
Day Two
Wednesday, May 22
8:00 am
-
9:15 am
Breakfast + Ask the Investor
9:15 am
-
9:55 am
Risky Move? How the Healthcare Industry is Taking On Risk
To get to the promised land of value-based care — improved outcomes, lowered cost, and greater patient and physician satisfaction — companies need to stand behind their products and services. That requires taking on risks in customer contracts and for payers to think about payment innovation. Learn from these leaders about how the healthcare industry is embracing risk.
MODERATOR
Michael Greeley
Co-Founder & General Partner
Flare Capital Partners
Full Bio
SPEAKERS
Diana Rhyne
Executive Director, Research & Innovation
WakeMed Health & Hospitals
Full Bio
Laura Fox
Director, Payment Innovation
Blue Shield of California
Full Bio
Seth Zuckerman
Chief Business Officer
Upward Health
Full Bio
Brian Montgomery
Chief Strategy Officer
GE Healthcare
Full Bio
9:55 am
-
11:05 am
Devices/Diagnostics Pitch Track
Startups focused on cardiology
CONTESTANTS
The Shape Sensing Company
Polynova Cardiovascular
JB HealthTech
General Prognostics (GPx)
CoraVie Medical
BioMEMS Diagnostics
EMCEE
Katie Adams
Senior Reporter
Full Bio
JUDGES
Lewis Kilongo
Principal
Unorthodox Ventures
Full Bio
David Kereiakes
Managing Partner
Windham Venture Partners
Full Bio
Ken Nelson
Partner
Medtech Advantage Fund
Full Bio
11:05 am
-
11:30 am
Networking Break
11:30 am
-
12:10 pm
How are Glp-1 Drugs Reshaping the Healthcare Industry?
Glp-1 drugs have fundamentally transformed the obesity crisis in the U.S. providing hope to many, and while these drugs are expensive, they have also reshaped the healthcare industry overall. Startups serving patients on Glp-1 drugs have cropped up helping patients get services beyond just the weekly injections. Doctors who weren’t treating obesity patients are now providing Glp-1 programs. Learn how are payers, service providers and doctors are viewing this landscape through an expert panel that will discuss the far-reaching impacts of these highly-touted drug class.
MODERATOR
Betty Pio
Partner
Kearney
Full Bio
SPEAKERS
Dr. Rekha Kumar
Chief Medical Officer
Found
Full Bio
Alexander Singh
CEO and Co-Founder
Alfie Health
Full Bio
12:10 pm
-
12:40 pm
Fireside Chat
Change Healthcare’s cybersecurity incident in February brought a large chunk of the healthcare industry to its knees affecting everyone from patients, providers, pharmacies and health systems. What can be done to stem the rising tide of cyber attacks on the health industry? Do policies need to change? What kind of investment do companies need to make to secure their data? Learn from a senior government official charged with protecting the nation’s critical infrastructure.
MODERATOR
Arundhati Parmar
Editor-in-Chief
MedCity News
Full Bio
SPEAKERS
Nitin Natarajan
Deputy Director
Cybersecurity and Infrastructure Security Agency (CISA)
Full Bio
12:40 pm
-
2:00 pm
Lunch
2:00 pm
-
2:35 pm
The Evolution of Precision Medicine
Initially, precision medicine primarily focused on genetic factors to tailor treatments to individual patients. However, the landscape has expanded to encompass a broader array of data sources, including genomic, clinical, environmental and lifestyle information. AI and ML now play a pivotal role in analyzing massive datasets, enabling more precise diagnostics and personalized treatment plans. Hear more about this paradigm shift from top players in the field.
SPEAKERS
Chris Dingman
Chief Commercial Officer
OncoHost
Full Bio
Nirdesh K. Gupta
Managing Director
Cedars Sinai Technology Ventures
Full Bio
2:35 pm
-
3:00 pm
Canadian Startup Pitch Competition
CONTESTANTS
OPPT Health
PragmaClin Research
Reach Orthopaedics
FemTherapeutics
3:00 pm
-
3:30 pm
Women’s Health Sector Matures
In 2024, there’s a welcome shift in investors finally giving women’s health the attention it deserves. While past investments concentrated on obstetrics/gynecology platforms and fertility services, there’s now a gradual diversification. Investors are expanding their interests in women’s health to encompass primary care, mental health, wellness, and various other services. Although pregnancy, fertility, and menopause remain substantial areas of investment, we are entering the next phase of advancing women’s health.
MODERATOR
Christiana DelloRusso
Partner
LRVHealth
Full Bio
SPEAKERS
Melissa Dennis
Chief Medical Officer
Partum Health
Full Bio
Melissa Lederer
Chief Operating Officer and Managing Partner
mHUB & mHUB Ventures
Full Bio
Joe Connolly
Co-founder & CEO
Visana Health
Full Bio
3:30 pm
-
4:00 pm
Networking Break
4:00 pm
-
5:10 pm
Healthtech: Consumer/Employer Pitch Track
Startups addressing women’s health
CONTESTANTS
Marma
NOMA AI
Mother’s Milk
Estrigenix Therapeutics
Coologics
GoNo Food Finder
EMCEE
Marissa Plescia
Reporter
Full Bio
JUDGES
Julien L. Pham
Founder and Managing Partner
3CC | Third Culture Capital
Full Bio
Carli Sapir
Founding Partner
Amboy Street Ventures
Full Bio
Samir Batra
Managing Partner
HIP